Mirae Asset Global ETFs Holdings
ZBIO

Mirae Asset Global ETFs Holdings’s Zenas BioPharma ZBIO Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio ZBIO Stock Details ZBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$277K Buy
14,386
+5,606
+64% +$126K ﹤0.01% 2183
2025
Q4 		$319K Buy
8,780
+1,319
+18% +$43.4K ﹤0.01% 2128
2025
Q3 		$166K Sell
7,461
-1,425
-16% -$23.2K ﹤0.01% 2420
2025
Q2 		$86.1K Sell
8,886
-100
-1% -$974 ﹤0.01% 2682
2025
Q1 		$71K Buy
8,986
+390
+5% +$3.05K ﹤0.01% 2764
2024
Q4 		$70.4K Buy
+8,596
New +$134K ﹤0.01% 2827

Other funds holding ZBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NA
NVP Associates Menlo Park, California $176M AUM 208.78% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's ZBIO Position: Q1 2026 in Review

Mirae Asset Global ETFs Holdings increased its Zenas BioPharma (ZBIO) stake by 64% in Q1 2026, buying an estimated $126K and bringing the position to 14,386 shares worth $277K. The position accounts for ﹤0.01% of the portfolio, ranked #2183.

Mirae Asset Global ETFs Holdings first reported a position in ZBIO in Q4 2024 and has held it in 6 quarters since. The position peaked at $319K in Q4 2025. 139 funds tracked by Wall St. Rank hold ZBIO as of Q1 2026.

  • Mirae Asset Global ETFs Holdings held 14,386 shares of Zenas BioPharma worth $277K as of Q1 2026.
  • Mirae Asset Global ETFs Holdings bought 5,606 Zenas BioPharma shares in Q1 2026, an estimated $126K.
  • Zenas BioPharma made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q1 2026, its #2183 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Zenas BioPharma in Q4 2024 and has held it in 6 quarters since.
  • Mirae Asset Global ETFs Holdings's Zenas BioPharma position peaked at $319K in Q4 2025.
  • 139 funds tracked by Wall St. Rank held Zenas BioPharma as of Q1 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q1 2026, filed 15 May 2026.